Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran

Ariana Kariminejad, Mohammadreza Barzgar, Bita Bozorgmehr, Elham Keshavarz, Mohamad Hasan Kariminejad, Dana S'Aulis, William B Rizzo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Sjögren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability. The disease is caused by mutations in the ALDH3A2 gene that encodes fatty aldehyde dehydrogenase. We describe 7 Iranian SLS patients from 5 unrelated consanguineous families. Sequencing of ALDH3A2 identified 4 novel mutations, including a 26-bp deletion (c.25_50del), small in-frame deletion (c.370_372del; p.G124del), a termination (p.Q35Ter) and a missense mutation (p.Lys211Glu). Bacterial expression of the p.Lys211Glu and p.G124del mutations showed little or no detectable enzyme activity. Three of the patients exhibited an unusual neuro-regressive clinical course associated with seizures, which may reflect the presence of unidentified genetic or environmental modifiers in this consanguineous population. This cohort represents the largest group of Iranian patients with molecularly confirmed SLS and expands the mutational and clinical spectrum of this disease.

Original languageEnglish (US)
Pages (from-to)139-144
Number of pages6
JournalEuropean Journal of Medical Genetics
Volume61
Issue number3
DOIs
StatePublished - Mar 2018

Fingerprint

Iran
long-chain-aldehyde dehydrogenase
Phenotype
Mutation
Ichthyosis
Missense Mutation
Intellectual Disability
Seizures
Enzymes
Population
Genes

Keywords

  • ALDH3A2
  • Ichthyosis
  • Intellectual disability
  • Spasticity

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran. / Kariminejad, Ariana; Barzgar, Mohammadreza; Bozorgmehr, Bita; Keshavarz, Elham; Kariminejad, Mohamad Hasan; S'Aulis, Dana; Rizzo, William B.

In: European Journal of Medical Genetics, Vol. 61, No. 3, 03.2018, p. 139-144.

Research output: Contribution to journalArticle

Kariminejad, A, Barzgar, M, Bozorgmehr, B, Keshavarz, E, Kariminejad, MH, S'Aulis, D & Rizzo, WB 2018, 'Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran', European Journal of Medical Genetics, vol. 61, no. 3, pp. 139-144. https://doi.org/10.1016/j.ejmg.2017.11.006
Kariminejad, Ariana ; Barzgar, Mohammadreza ; Bozorgmehr, Bita ; Keshavarz, Elham ; Kariminejad, Mohamad Hasan ; S'Aulis, Dana ; Rizzo, William B. / Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran. In: European Journal of Medical Genetics. 2018 ; Vol. 61, No. 3. pp. 139-144.
@article{237184c533444168b10314d1091d149a,
title = "Novel mutations and a severe neurological phenotype in Sj{\"o}gren-Larsson syndrome patients from Iran",
abstract = "Sj{\"o}gren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability. The disease is caused by mutations in the ALDH3A2 gene that encodes fatty aldehyde dehydrogenase. We describe 7 Iranian SLS patients from 5 unrelated consanguineous families. Sequencing of ALDH3A2 identified 4 novel mutations, including a 26-bp deletion (c.25_50del), small in-frame deletion (c.370_372del; p.G124del), a termination (p.Q35Ter) and a missense mutation (p.Lys211Glu). Bacterial expression of the p.Lys211Glu and p.G124del mutations showed little or no detectable enzyme activity. Three of the patients exhibited an unusual neuro-regressive clinical course associated with seizures, which may reflect the presence of unidentified genetic or environmental modifiers in this consanguineous population. This cohort represents the largest group of Iranian patients with molecularly confirmed SLS and expands the mutational and clinical spectrum of this disease.",
keywords = "ALDH3A2, Ichthyosis, Intellectual disability, Spasticity",
author = "Ariana Kariminejad and Mohammadreza Barzgar and Bita Bozorgmehr and Elham Keshavarz and Kariminejad, {Mohamad Hasan} and Dana S'Aulis and Rizzo, {William B}",
year = "2018",
month = "3",
doi = "10.1016/j.ejmg.2017.11.006",
language = "English (US)",
volume = "61",
pages = "139--144",
journal = "European Journal of Medical Genetics",
issn = "1769-7212",
publisher = "Elsevier Masson SAS",
number = "3",

}

TY - JOUR

T1 - Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran

AU - Kariminejad, Ariana

AU - Barzgar, Mohammadreza

AU - Bozorgmehr, Bita

AU - Keshavarz, Elham

AU - Kariminejad, Mohamad Hasan

AU - S'Aulis, Dana

AU - Rizzo, William B

PY - 2018/3

Y1 - 2018/3

N2 - Sjögren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability. The disease is caused by mutations in the ALDH3A2 gene that encodes fatty aldehyde dehydrogenase. We describe 7 Iranian SLS patients from 5 unrelated consanguineous families. Sequencing of ALDH3A2 identified 4 novel mutations, including a 26-bp deletion (c.25_50del), small in-frame deletion (c.370_372del; p.G124del), a termination (p.Q35Ter) and a missense mutation (p.Lys211Glu). Bacterial expression of the p.Lys211Glu and p.G124del mutations showed little or no detectable enzyme activity. Three of the patients exhibited an unusual neuro-regressive clinical course associated with seizures, which may reflect the presence of unidentified genetic or environmental modifiers in this consanguineous population. This cohort represents the largest group of Iranian patients with molecularly confirmed SLS and expands the mutational and clinical spectrum of this disease.

AB - Sjögren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability. The disease is caused by mutations in the ALDH3A2 gene that encodes fatty aldehyde dehydrogenase. We describe 7 Iranian SLS patients from 5 unrelated consanguineous families. Sequencing of ALDH3A2 identified 4 novel mutations, including a 26-bp deletion (c.25_50del), small in-frame deletion (c.370_372del; p.G124del), a termination (p.Q35Ter) and a missense mutation (p.Lys211Glu). Bacterial expression of the p.Lys211Glu and p.G124del mutations showed little or no detectable enzyme activity. Three of the patients exhibited an unusual neuro-regressive clinical course associated with seizures, which may reflect the presence of unidentified genetic or environmental modifiers in this consanguineous population. This cohort represents the largest group of Iranian patients with molecularly confirmed SLS and expands the mutational and clinical spectrum of this disease.

KW - ALDH3A2

KW - Ichthyosis

KW - Intellectual disability

KW - Spasticity

UR - http://www.scopus.com/inward/record.url?scp=85036514573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036514573&partnerID=8YFLogxK

U2 - 10.1016/j.ejmg.2017.11.006

DO - 10.1016/j.ejmg.2017.11.006

M3 - Article

C2 - 29183715

AN - SCOPUS:85036514573

VL - 61

SP - 139

EP - 144

JO - European Journal of Medical Genetics

JF - European Journal of Medical Genetics

SN - 1769-7212

IS - 3

ER -